Latest Blog Posts
Combo Treatment Is More Effective for Advanced Neuroendocrine Tumors
Pairing Lutathera and octreotide as initial treatment shrank tumors for long periods.
NCI Launches Virtual Clinical Trials Office
Remote support staff will include research nurses, clinical research associates, and clinical data specialists.
Blood Test May Help Guide Colorectal Cancer Treatment
Measuring tumor DNA in the blood may help guide who should get chemotherapy after surgery.
Latest Press Releases
The Virtual Clinical Trials Office aims to tackle the steep decline in participation in NCI-
funded cancer clinical trials by providing a centralized team of support staff working
remotely to assist with NCI-funded clinical trials activities.
The Cancer Screening Research Network (CSRN) will investigate how to identify cancers earlier, when they may be easier to treat, to ultimately save lives. In late 2024, CSRN plans to launch the Vanguard Study on Multi-Cancer Detection, a pilot study to inform the design of a larger trial of multi-cancer detection tests.
W. Kimryn Rathmell, M.D., Ph.D., begins her tenure as the 17th director of the National Cancer Institute on December 18, 2023. She comes to NCI from Vanderbilt University Medical Center in Nashville, Tennessee, where she served as the Hugh Jackson Morgan Chair in Medicine, chair of the Department of Medicine, and physician-in-chief.
New approach may increase the effectiveness of T-cell-based immunotherapy treatments against solid tumors.
NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation
Steven A. Rosenberg, M.D., Ph.D., has been awarded the National Medal of Technology and Innovation by President Biden. It is the nation's highest honor for technological achievement.